Awful Jobs Report: ...
Health Care: Drugs
Cell Therapeutics Inc. (CTIC: NASDAQ)
$0.86 -0.03 | -3.86%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 47.05M | 22.65M | 37.81M | 10.07M |
| Receivables | 0.00 | 0.00 | 0.00 | 8.49M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 51.08M | 26.90M | 42.16M | 28.16M |
| Property, Plant & Equipment, Gross | 15.54M | 16.53M | 15.81M | 33.00M |
| Accumulated Depreciation & Depletion | 11.94M | 13.11M | 12.38M | 28.68M |
| Property, Plant & Equipment, Net | 3.60M | 3.43M | 3.43M | 4.32M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 7.56M | 6.20M | 6.94M | 14.69M |
| Total Non-Current Assets | 11.16M | 26.69M | 27.43M | 36.08M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 62.24M | 53.59M | 69.60M | 64.24M |
| Accounts Payable | 5.75M | 6.04M | 7.30M | 9.33M |
| Short Term Debt | 970.00K | 1.72M | 1.31M | 757.00K |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 2.83M |
| Total Current Liabilities | 17.78M | 41.07M | 63.86M | 42.30M |
| Long Term Debt | 2.98M | 4.21M | 23.64M | 145.28M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 13.46M | 13.46M | 865.00K | 319.00K |
| Minority Interest | -259.00K | -194.00K | -252.00K | -126.00K |
| Total Non-Current Liabilities | 15.74M | 17.27M | 24.30M | 145.60M |
| Total Liabilities | 33.52M | 58.34M | 88.16M | 187.90M |
| Preferred Stock Equity | 6.74M | 0.00 | 0.00 | 8.40M |
| Common Stock Equity | 21.98M | -4.75M | -18.56M | -132.06M |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 1.74B | 1.58B | 1.42B | 1.19B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -1.71B | -1.58B | -1.43B | -1.31B |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -8.04M | -7.97M | -8.41M | -7.81M |
| Total Capitalization | 31.70M | -540.00K | 5.08M | 21.62M |
| Total Equity | 28.72M | -4.75M | -18.56M | -123.66M |
| Total Liabilities & Stock Equity | 62.24M | 53.59M | 69.60M | 64.24M |
| Total Common Shares Outstanding | 203.07M | 135.63M | 98.38M | 53.64M |
| Preferred Shares | 10.00K | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 171.47M | 114.11M | 76.39M | 4.83M |
| Diluted Weighted Shares Outstanding | 171.47M | 114.11M | 76.39M | 4.83M |
| Number of Employees | 95 | 88 | 104 | 194 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CTIC
- Portfolio NameUser Type
- ContributorUnder-$10 Setting Up To Tra...
- User2012 stock
- ContributorCancer Drug Stocks to Trade...
- UserImagine!
- Userfrankiesun09@gmail.com
- UserASCO 2010
- Contributor10 Biotech Stocks Facing FD...
- Userbiotech121
- UserJswaim
- UserSLITraders
Latest CTIC Headlines from TheStreet
- Cell Therapeutics Juggles Chainsaws To Distract Investors From Its Dead-End Course 04.19.12 | 03:04 pm
- The 5 Dumbest Things on Wall Street This Week: Feb. 3 02.03.12 | 06:02 am
- The 5 Dumbest Things on Wall Street: Feb. 3
02.03.12 | 05:02 am - Cell Therapeutics Pulls Cancer Drug After CEO Boasted About Approval Chances 01.30.12 | 05:01 am
- Play TheStreet's FDA Drug-Approval Contest 01.23.12 | 08:01 am
- 5 Under-$10 Stocks Set to Soar 12.29.11 | 06:12 pm
- The Worst Biotech CEO of 2011 Is ... 12.09.11 | 07:12 am
- Biotech Stock Mailbag: Affymax 12.02.11 | 06:12 am
- 22 Hot Drugs Facing FDA Approval in 2012 11.29.11 | 08:11 am
- 10 Best Mutual Funds for 2012 11.16.11 | 07:11 am
Press Releases for CTIC
- Cell Therapeutics Completes Acquisition Of Pacritinib A Highly Selective JAK2 Inhibitor - PR Newswire 06.04.12 | 01:06 am
- Cell Therapeutics To Host Investor And Analyst Meeting To Discuss Targeted Agents In Myelofibrosis And High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia On Sunday, June 3, 2012, In Chicago - PR Newswire 06.01.12 | 04:06 pm
- Cell Therapeutics' Pixuvri® Phase 3 Clinical Trial Results Published In The Lancet Oncology - PR Newswire 05.31.12 | 01:05 am
- Cell Therapeutics' Aequus BioPharma Validates Its Proprietary GlycoPolymer Technology For The Extension Of The Half-life Of Therapeutic Protein Drugs - PR Newswire 05.30.12 | 01:05 am
- Cell Therapeutics To Host Investor And Analyst Meeting To Discuss Targeted Agents In Myelofibrosis And High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia On Sunday, June 3, 2012, In Chicago - PR Newswire 05.29.12 | 04:05 pm
- Cell Therapeutics Announces Institutional Investor To Purchase $40 Million Of Convertible Preferred Stock And Warrants To Purchase Common Stock - PR Newswire 05.29.12 | 03:05 am
- Cell Therapeutics' Pixuvri® Approved In European Union As Monotherapy To Treat Adult Patients With Multiply Relapsed Or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas - PR Newswire 05.10.12 | 02:05 pm
- Cell Therapeutics Enters Into Agreement To Acquire Pacritinib, A Novel Highly Selective JAK2 Inhibitor Phase 3 Candidate For Myelofibrosis - PR Newswire 04.19.12 | 01:04 am
- University Of Washington's Neuro-Oncology Program To Investigate Cell Therapeutics' Drug Candidate OPAXIO⢠(Paclitaxel Poliglumex) Plus Radiotherapy For Glioblastoma Multiforme, A Highly Malignant Brain Cancer - PR Newswire 03.27.12 | 01:03 am
- European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri⢠- PR Newswire 02.17.12 | 07:02 am
Partner Headlines for CTIC
- 5 Biotech Stocks That Could Double - Seeking Alpha 02.01.12 | 07:02 am
- Cell Therapeutics Plummeting on NDA Withdrawl - Benzinga 01.30.12 | 09:01 am
- US Panel to Review CTIC's Pixantrone - Analyst Blog - Zacks 01.04.12 | 10:01 am
- Mid-Day Update: Stocks Higher; Investors Cheer European Fiscal Deal - NASDAQ 12.09.11 | 05:12 pm
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.11.11 | 09:11 am
- CTIC Loss Widens, Resubmits NDA - Analyst Blog - Zacks 10.27.11 | 10:10 am
- 19 Small Cap Stocks Boosted By Institutional Buying - Seeking Alpha 10.11.11 | 08:10 am
- Cell Therapeutics Efforts Validated - Analyst Blog - Zacks 10.07.11 | 04:10 pm
- Morning Market Movers - Benzinga 08.31.11 | 09:08 am
